Linked Life Data

18854779

Source:http://linkedlifedata.com/resource/pubmed/id/18854779

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-10-15
pubmed:abstractText
High-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin (CTC) has been developed as a possible curative treatment modality in several solid tumours. However, a large interindividual variability in toxicity is encountered in high-dose chemotherapy. A priori identification of patients at risk for toxicity could be an attractive prospect. Genotyping of genes encoding drug-metabolising enzymes might provide such a tool.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1744-6872
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1009-15
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.
pubmed:affiliation
Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, The Netherlands. Corine.Ekhart@slz.nl
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't